Endo closes Indevus share offer at second time of asking
This article was originally published in Scrip
Executive Summary
Endo Pharmaceuticalshas completed its tender offer for all outstanding shares of Indevus Pharmaceuticalsafter 70.9 million shares were validly tendered, representing around 89% of Indevus's issued and outstanding shares.